Jane Street Group, LLC Bluejay Diagnostics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.38 - $0.87 $4,656 - $10,660
12,254 New
12,254 $5,000
Q2 2022

Aug 16, 2022
SELL
$0.94 - $1.63 $14,958 - $25,938
-15,913 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$0.86 - $2.92 $6,738 - $22,878
-7,835 Reduced 32.99%
15,913 $18,000
Q4 2021

Feb 15, 2022
BUY
$2.33 - $5.32 $55,332 - $126,339
23,748 New
23,748 $61,000

About Bluejay Diagnostics, Inc.

BJDX Quotes by TradingView
  • Ticker BJDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,152,300
  • Market Cap $71.3M
  • Description
  • Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...
More about BJDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email